Zhejiang Xinan Chemical Industrial Group Co.,Ltd (SHA:600596)
12.49
-0.22 (-1.73%)
Apr 30, 2026, 3:00 PM CST
SHA:600596 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,652 | 2,521 | 4,270 | 3,571 | 2,175 |
Trading Asset Securities | 20.81 | 16.6 | 16.47 | 17.62 | 189.82 |
Cash & Short-Term Investments | 2,672 | 2,538 | 4,286 | 3,589 | 2,365 |
Cash Growth | 5.29% | -40.79% | 19.43% | 51.78% | 47.87% |
Accounts Receivable | 2,126 | 2,236 | 2,007 | 2,212 | 2,898 |
Other Receivables | 240.27 | 73.6 | 210.3 | 263.33 | 227.81 |
Receivables | 2,367 | 2,310 | 2,217 | 2,475 | 3,125 |
Inventory | 2,538 | 2,916 | 2,602 | 2,663 | 2,940 |
Prepaid Expenses | - | 1.18 | 1.17 | 2.87 | 0.27 |
Other Current Assets | 487.78 | 645.75 | 494.62 | 405.65 | 527.34 |
Total Current Assets | 8,065 | 8,411 | 9,601 | 9,136 | 8,958 |
Property, Plant & Equipment | 11,243 | 11,379 | 9,647 | 7,187 | 5,519 |
Long-Term Investments | 1,075 | 1,231 | 1,254 | 1,310 | 1,282 |
Goodwill | 167.02 | 187.95 | 201.98 | 96.79 | 105.77 |
Other Intangible Assets | 1,027 | 1,064 | 1,114 | 900.82 | 771.54 |
Long-Term Accounts Receivable | - | 117.51 | 144.02 | 149.58 | 127.79 |
Long-Term Deferred Tax Assets | 89.78 | 67.92 | 60.64 | 107.33 | 81.6 |
Long-Term Deferred Charges | 18.28 | 20.5 | 19.74 | 12.13 | 14.11 |
Other Long-Term Assets | 307.58 | 132.39 | 297.17 | 350.08 | 339.61 |
Total Assets | 21,993 | 22,612 | 22,340 | 19,249 | 17,199 |
Accounts Payable | 3,578 | 4,325 | 3,470 | 3,279 | 3,422 |
Accrued Expenses | 229.28 | 264.57 | 290.65 | 345.35 | 351.46 |
Short-Term Debt | 699.51 | 517.83 | 460.24 | 331.11 | 438.96 |
Current Portion of Long-Term Debt | - | 285.59 | 537.1 | 286.1 | 199.8 |
Current Portion of Leases | - | 5.1 | 5.3 | 14.24 | 8.88 |
Current Income Taxes Payable | 147.62 | 59.69 | 67.13 | 122.01 | 347.5 |
Current Unearned Revenue | 392.72 | 446.06 | 445.86 | 450.15 | 716.74 |
Other Current Liabilities | 1,082 | 467.41 | 328.24 | 252.05 | 271.12 |
Total Current Liabilities | 6,129 | 6,371 | 5,605 | 5,080 | 5,756 |
Long-Term Debt | 1,931 | 2,345 | 2,367 | 1,409 | 1,483 |
Long-Term Leases | 3.66 | 9.4 | 10.44 | 16.02 | 18.64 |
Long-Term Unearned Revenue | 200.35 | 110.67 | 84.01 | 71.72 | 51.7 |
Long-Term Deferred Tax Liabilities | 21.71 | 26.92 | 31.14 | 26.97 | 13.04 |
Other Long-Term Liabilities | 124.55 | 138.52 | 135.38 | 112.63 | 41.4 |
Total Liabilities | 8,410 | 9,002 | 8,233 | 6,716 | 7,364 |
Common Stock | 1,350 | 1,350 | 1,350 | 1,146 | 818.39 |
Additional Paid-In Capital | 2,153 | 2,144 | 2,440 | 650.14 | 977.22 |
Retained Earnings | 8,859 | 8,847 | 8,934 | 9,659 | 7,114 |
Comprehensive Income & Other | 98.66 | 105.31 | 89.77 | 90.04 | 33.89 |
Total Common Equity | 12,460 | 12,446 | 12,813 | 11,545 | 8,943 |
Minority Interest | 1,122 | 1,164 | 1,293 | 988.3 | 891.68 |
Shareholders' Equity | 13,582 | 13,610 | 14,107 | 12,533 | 9,835 |
Total Liabilities & Equity | 21,993 | 22,612 | 22,340 | 19,249 | 17,199 |
Total Debt | 2,634 | 3,163 | 3,380 | 2,056 | 2,150 |
Net Cash (Debt) | 38.04 | -625.09 | 906.25 | 1,533 | 215.07 |
Net Cash Growth | - | - | -40.89% | 612.82% | - |
Net Cash Per Share | 0.03 | -0.49 | 0.81 | 1.34 | 0.19 |
Filing Date Shares Outstanding | 1,292 | 1,350 | 1,350 | 1,146 | 1,146 |
Total Common Shares Outstanding | 1,292 | 1,350 | 1,350 | 1,146 | 1,146 |
Working Capital | 1,936 | 2,040 | 3,996 | 4,055 | 3,202 |
Book Value Per Share | 9.64 | 9.22 | 9.49 | 10.08 | 7.81 |
Tangible Book Value | 11,266 | 11,194 | 11,497 | 10,547 | 8,066 |
Tangible Book Value Per Share | 8.72 | 8.29 | 8.52 | 9.21 | 7.04 |
Buildings | - | 3,679 | 3,555 | 2,690 | 2,426 |
Machinery | - | 8,223 | 8,086 | 6,702 | 6,081 |
Construction In Progress | - | 4,504 | 2,857 | 2,088 | 772.21 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.